Impiricus is a healthcare technology company that has built an AI-powered platform designed to connect pharmaceutical companies with healthcare professionals (HCPs). The company's core product, the HCP Engagement Engine, uses artificial intelligence and real-time channels to deliver evidence-based pharmaceutical resources directly to physicians and other providers. A significant portion of its network targets the roughly 30% of physicians who do not engage through traditional outreach methods.
The platform operates through what the company describes as the largest opted-in network of healthcare providers in its market. Its metrics show that 95% of messages sent via the engine are opened within three minutes. Impiricus reports that its technology is helping approximately one million patients access therapy in 2025.
The company was recognised as the fastest-growing firm in North America on Deloitte's 2025 Technology Fast 500 list. Impiricus is active across North America, operating within the healthcare and pharmaceutical sectors.
